NCT00751023

Effects of Modafinil in Methamphetamine Dependence

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Medical University of South Carolina · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Methamphetamine dependence is a serious public health problem with no pharmacologic treatments currently available. Relapse rates are high in this population. Exposure to cues previously associated with methamphetamine use may induce profound craving in abstinent individuals. Chronic methamphetamine abuse is associated with selective cognitive deficits that may undermine successful participation in psychosocial treatments. Medications which improve cognitive deficits in methamphetamine-dependent individuals may improve abstinence rates, especially in the critical early period of recovery. Modafinil is an atypical stimulant medication with evidence to support its use in treating cocaine dependence and attention deficit/hyperactivity disorder. The proposed studies are designed to evaluate modafinil as a potential treatment for methamphetamine dependence and its cognitive sequelae.

Conditions

• Methamphetamine Dependence

Interventions

Type	Name	Description
DRUG	Modafinil	400 mg daily for four weeks
DRUG	Placebo	Placebo 2 tablets daily for 4 weeks

Timeline

• Start date: 2009-02-01
• Primary completion: 2010-07-01
• Completion: 2010-07-01
• First posted: 2008-09-11
• Last updated: 2019-06-13
• Results posted: 2019-06-13

Locations

1 site across 1 country: United States